Second is endocrine modulation; rTMS treatment for insomnia was shown to significantly reduce serum cortisol, adrenocorticotropic hormone (ACTH), high-sensitivity thyroid-stimulating hormone, and free T3/T4 levels alongside improvements in insomnia symptoms. The gene discussed is POMC; the disease is insomnia.